Finally, by immunoblotting and flow cytometry, they demonstrated that phosphorylation of BCR-ABL1 is fostered in AQP5-overexpressing CML cells and reduced in AQP5 siRNA-treated CML cells. The gene discussed is AQP5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.